Cargando…
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
Non-small cell lung cancer (NSCLC) is the deadliest form of cancer worldwide, due in part to its proclivity to metastasize. Identifying novel drivers of invasion and metastasis holds therapeutic potential for the disease. We conducted a gain-of-function invasion screen, which identified two separate...
Autores principales: | Bajaj, Rakhee, Kundu, Samrat T., Grzeskowiak, Caitlin L., Fradette, Jared J., Scott, Kenneth L., Creighton, Chad J., Gibbons, Don L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539228/ https://www.ncbi.nlm.nih.gov/pubmed/32753652 http://dx.doi.org/10.1038/s41388-020-01410-z |
Ejemplares similares
-
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis
por: Bajaj, Rakhee, et al.
Publicado: (2022) -
TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins
por: Kundu, Samrat T., et al.
Publicado: (2018) -
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis
por: Bajaj, Rakhee, et al.
Publicado: (2022) -
MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs
por: Ochieng, Joshua Kapere, et al.
Publicado: (2020) -
KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion
por: Meng, Xiangui, et al.
Publicado: (2022)